=============================================================

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10QSB

 -------- ---------------------------------------------------------------------
 [X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
          Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED JULY 31, 2004
 -------- ---------------------------------------------------------------------
          OR
 -------- ---------------------------------------------------------------------
 [ ]      Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
 -------- ---------------------------------------------------------------------
          For the transition period from to
 -------- ---------------------------------------------------------------------

                         COMMISSION FILE NUMBER: 0-30351

                                True Health, Inc.
             (Exact name of registrant as specified in its charter)

-------------------------------------------------- ----------------------------
       Utah                                               75-2263732
-------------------------------------------------- ----------------------------
(State of other jurisdiction                       (IRS Employer Identification
 of incorporation or organization)                  Number)
-------------------------------------------------- ----------------------------

                          Kelsey House, 77 High Street
                                 Beckenham, Kent
                                   UK BR3 1AN
                    (Address of principal executive offices)

                             +(44) (0) 208 658 9575
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
                           Yes [ x ]        No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of

 July 31, 2004:      51,416,875

          =============================================================



<PAGE>



                                TRUE HEALTH, INC.
                           CONSOLIDATED BALANCE SHEET
                                  July 31, 2004
                                   (unaudited)
<TABLE>

ASSETS

<S>                                                                                           <C>
Current Assets
  Cash                                                                                        $    48,181
  Accounts receivable, net                                                                        980,197
  Inventory                                                                                       241,334
  Other                                                                                            98,110
                                                                                              -----------

         Total Current Assets                                                                   1,367,823
                                                                                              -----------

Equipment, net of accumulated depreciation                                                        253,535
                                                                                              -----------

TOTAL ASSETS                                                                                  $ 1,621,358
                                                                                              ===========


LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
  Note payable to factor                                                                      $   671,584
  Current portion of notes payable                                                                136,506
  Accounts payable                                                                                195,045
  Accrued expenses                                                                                314,371
  Accounts payable to stockholder                                                                 127,174
                                                                                              -----------

         Total Current Liabilities                                                              1,444,680
                                                                                              -----------

Long-term portion of notes payable                                                                135,223
                                                                                              -----------

         Total Liabilities                                                                      1,579,903
                                                                                              -----------

Stockholders' Equity
  Common stock, $.01 par value; 100,000,000 shares
  authorized; 51,416,875 shares issued and outstanding                                            514,169
  Additional paid in capital                                                                    1,592,088
  Accumulated deficit                                                                          (2,050,628)
  Accumulated other comprehensive loss                                                            (14,174)
                                                                                              -----------

  Total Stockholders' Equity                                                                       41,455
                                                                                              -----------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                    $ 1,621,358
                                                                                              ===========

</TABLE>
<PAGE>


                                TRUE HEALTH, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
            Three Months and Six Months Ended July 31, 2004 and 2003
                                   (unaudited)



<TABLE>

                                 Three Months Ended                  Six Months Ended
                               2004              2003             2004             2003
                             ----------        ----------        ----------      ----------
<S>                        <S>                 <C>               <C>             <C>
Revenue
- Equipment rentals and sales   $  510,403        $  281,350       $ 1,006,777      $  597,650
- Radiographer services
     and placement fees    1,095,665                 571,495         2,246,740           815,562
- Other                    10,624                      8,720            20,763            16,596
                          ----------               ----------        ----------      ----------

Total Revenues             1,616,692                 861,565         3,274,281         1,429,808
Cost of sales              1,032,943                 497,868         2,094,743           780,532
                          ----------               ----------        ----------      ----------

Gross margin               583,749                   363,697         1,179,538           649,276
                          ----------               ----------        ----------      ----------

General and administrative
- Non-cash professional fees 600,000                 499,448           600,000          499,448
- Other                    749,322                   411,541         1,405,340           767,868
Depreciation               35,465                     30,251            61,238            58,173
                          ----------               ----------        ----------      ----------

  Total operating expenses 1,384,787                 941,240         2,066,578         1,325,489
                          ----------               ----------        ----------      ----------

Net Operating Loss         (801,038)                (577,543)         (887,040)         (676,213)

Interest income            0                               0                 0                19
Interest expense           (21,147)                  (20,611)          (24,164)          (38,072)
                          ----------               ----------        ----------      ----------

Net loss before taxes      (822,185)                (598,154)         (911,204)         (714,266)

Income tax expense         (897)                                             0
                          ----------               ----------        ----------      ----------

Net Loss                   $ (823,082)              (598,154)       $ (911,204)       $ (714,266)
                          ==========                ==========        ==========      ==========

Basic and diluted loss
     per share             $    (0.02)          $    (0.00)       $    (0.02)$    (0.01)

Weighted average shares
     outstanding           51,123,397             40,889,292        50,679,055        39,194,646


</TABLE>






                                TRUE HEALTH, INC.
                      STATEMENTS OF CONSOLIDATED CASH FLOW
                     Six Months Ended July 31, 2004 and 2003
                                   (unaudited)
<TABLE>
                                                                                   2004                  2003
                                                                                  ----------             ---------
<S>                                                                               <C>                    <C>
Cash Flows From Operating Activities
  Net loss                                                                         $(911,204)            $(714,266)
  Adjustments to reconcile net loss to net cash
    used in operating activities:
    Depreciation                                                                      61,232                58,173
    Stock issued for services                                                        600,000               442,247
    Stock warrants issued for services                                                     -                57,144
    Imputed interest on shareholder notes payable                                      6,421                15,497
    Changes in:
         Accounts receivable                                                        (283,380)             (161,325)
         Inventory                                                                  (136,425)               42,731
         Other current assets                                                        (25,610)              (12,516)
         Accounts payable                                                              76,020               20,981
         Accrued expenses                                                              57,242              54,436
                                                                                   ---------             ---------

  Net Cash Used in Operating Activities                                             (555,704)             (196,841)
                                                                                   ---------             ---------
Cash Flows Used in Investing Activities
  Purchase of equipment                                                              (69,312)              (61,353)
                                                                                   ---------             ---------
Cash Flows From Financing Activities
  Proceeds from exercise of warrants for stock                                       475,000                     -
  Net change in note payable to factor                                               275,845               129,437
  Net change in note payable to bank loan                                           (197,332)               19,654
  Net change in note payable to related party                                       (160,405)              111,171
                                                                                   ---------             ---------

  Net Cash Provided By Financing Activities                                          393,108               260,262
                                                                                  ---------              ---------

Currency translation adjustment                                                       23,443                   187
                                                                                   ---------             ---------

Net change in cash                                                                  (208,465)                2,255
Cash at beginning of period                                                          256,646                   255
                                                                                   ---------             ---------

Cash at end of period                                                               $  48,181            $   2,510
                                                                                   =========             =========

</TABLE>

<PAGE>


                                 TRUE HEALTH INC
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of True Health Inc.
(True Health) have been prepared in accordance with accounting principles
generally accepted in the United States of America and the rules of the
Securities and Exchange Commission ("SEC"), and should be read in conjunction
with the audited financial statements and notes thereto contained in True
Health, Inc.'s Annual Financial Statements filed with the SEC on Form 10-K and
in respect of the comparative period, the significant acquisition statement
filed with the SEC on Form 8-K. In the opinion of management, all adjustments,
consisting of normal recurring adjustments, necessary for a fair presentation of
financial position and the results of operations for the interim periods
presented have been reflected herein. The results of operations for interim
periods are not necessarily indicative of the results to be expected for the
full year. Notes to the financial statements which would substantially duplicate
the disclosure contained in the audited financial statements for the most recent
fiscal year ended to January,31 2004, as reported in the Form 10-KSB, have been
omitted.

NOTE 2 - COMMON STOCK

During the quarter ended July 31, 2004, 1,000,000 shares valued at $600,000 were
issued to consultants for services in 2004.



ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Important Information Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Those statements
include indications regarding our intent, belief or current expectations,
including our plans with respect to the sourcing, manufacturing, marketing and
distribution of our products and services, the belief that current levels of
cash and cash equivalents together with cash from operations and existing credit
facilities will be sufficient to meet its working capital requirements for the
next twelve months, our expectations with respect to the performance of the
counterparties to its letter of credit agreements, our plans to invest in
derivative instruments and the collection of accounts receivable, our beliefs
and intent with respect to and the effect of changes in financial accounting
rules on its financial statements. Such statements are subject to a variety of
risks and uncertainties, many of which are beyond the our control, which could
cause actual results to differ materially from those contemplated in such
forward-looking statements, which include, among other things, (i) changes in
the marketplace for our products and services, (ii) the introduction of new
products or pricing changes by our competitors, (iii) changes in exchange rates,
and (iv) changes in the economy. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date hereof. We undertake no obligation to update or revise
the information contained in this Quarterly Report on Form 10-QSB, whether as a
result of new information, future events or circumstances or otherwise.

Critical accounting policies

We have identified the policies below as critical to our business operations and
the understanding of our results of operations. The impact and any associated
risks related to these policies on our business operations is discussed
throughout Management's Discussion and Analysis of Financial Condition and
Results of Operations where such policies affect our reported and expected
financial results. The preparation of this Quarterly Report on Form 10-QSB
requires us to make estimates and assumptions that affect the reported amount of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of our financial statements, and the reported amounts of revenue and
expenses during the reporting period. There can be no assurance that actual
results will not differ from those estimates.

1) Allowance for doubtful accounts

We evaluate the adequacy of the allowance for doubtful accounts at the end of
each quarter. In performing this evaluation, we analyze the payment history of
significant past due accounts, subsequent cash collections on these accounts and
comparative accounts receivable aging statistics. Based on this information,
along with consideration of the general strength of the economy, we develop what
we consider to be a reasonable estimate of the uncollectible amounts included in
accounts receivable. This estimate involves our significant judgment. Actual
uncollectible amounts may differ from our estimate.



2) Provision for obsolete inventory

We estimate our provision for obsolete inventory based on customer orders sold
below cost, to be shipped in the following period and on the amount of similar
unsold inventory at period end. We analyze recent sales and gross margins on
unsold inventory in further estimating the inventory provision. The impact of
the inventory provision is reflected in cost of sales and the related gross
margins in the period that management deems that inventory has become obsolete.
This estimate involves our significant judgment. Actual gross margins on sales
of excess inventory may differ from our estimate.


Three Months Ended July 31, 2004 Compared to Three Months Ended July 31, 2003

Revenue

Total revenue for the three months ended July 31, 2004 was $1,616,692. This
represents an increase of $755,127 or 87.6%, when compared to revenue of
$861,565 for the three months ended July 31, 2003.

Revenue from the equipment rentals and sales segment increased by $229,053, or
81.4%, to $510,403 in the three months ended July 31, 2004 compared to $281,350
in the three months ended July 31, 2003. This increase reflects the continued
growth in the business over the past year which mainly arose from an increase in
the customer base and through our geographic expansion via our Distributor
Network.

Revenue from the recruitment services and placement of radiographers, socal
workers and nurses increased by $524,170 to $1,095,665 for the three months
ended July 31, 2004. This represents a 91.7% increase on the three months to
July 31, 2003.


Cost of sales

Cost of sales for the three months ended July 31, 2004, compared to the three
months ended July 31, 2003 are shown below:


                                   Three months ended      Three months ended
                                     July 31, 2004        July 31, 2003

Equipment rentals and sales         $137,180  26.8%     $ 81,329  28.9%

Recruitment services and             895,763  81.8%     $416,539  72.9%
 - placement fees

Total                             $1,032,943  63.3%     $497,868  57.8%


The total Gross Profit increased by $220,052 (60.5%) in the second quarter to
$583,749 compared with the three months ended July 31, 2003 of $363,697.



<PAGE>


General and administrative overheads

General and administrative overheads, excluding consideration for professional
fees which was paid for by way of shares for the three months to July 31, 2004
rose to $749,322 from $411,541 for the same period last year. Total operating
expenses amounted to $1,384,787 compared to $941,240 for the three months to
July 31, 2003. The main reasons for this increase are as follows:

o An increase in the number of sales staff,to facilitate the growth in revenues
o An increase in experienced employees and senior staff in order to support the
expansion of business o An increase in other office related costs reflecting the
increase in staff and revenues o An increase in consultancy fees o Increase in
costs associated with additional warehousing and inventory storage facilities



Interest expense

Net Interest expense of $21,147 for the three months ended July 31, 2004, is
compared with $20,611 for the three months ended July 31, 2003.


Liquidity and Capital Resources

We have relied primarily on asset-based borrowings, internally generated funds,
stockholder investment and loans, together with trade credit to finance our
operations. Our capital requirements primarily result from working capital
needed to support operations, including increases in inventory and accounts
receivable. Our working capital position has improved from a deficit of $255,335
as of January 31, 2004 to a deficit of $76,857 as of July 31, 2004. This
improvement has been mainly due to the contribution of proceeds from
shareholders. As of July 31, 2004, we had cash and cash equivalents of $48,181
compared to $2,510 as of July 31, 2003.

Operating Cash Flow

Net cash used in operating activities for the six months ended July 31, 2004 was
$555,704 compared with net cash used of $196,841 for the six months ended July
31, 2003. This is primarily due to the rise in inventories in order to meet
future orders, accounts receivable and the loss for the period.

Credit Facilities

We have a loan agreement with bankers, HSBC, for a term loan that advanced
$237,000 in January 2003 and is due for repayment by November 2007. The loan
attracts a variable rate interest of 2% over UK base rate and there is a
floating charge over the assets of the Company (6.75% at July 31, 2004).

We also have an accounts receivable factoring arrangement with Venture Finance
which is secured by a floating charge over our assets. This facility has
attracts variable rate interest of 1.75% over UK base rate (6.5% at July 31,
2004).

We believe that current levels of cash and cash equivalents ($48,181 at July 31,
2004) together with cash from operations and funds available under our credit
facilities and additional funding exercises, will be sufficient to meet our
capital requirements for the next twelve months.


Six Months Ended July 31, 2004 Compared to Six Months Ended July 31, 2003

Revenue

Total revenue for the six months ended July 31, 2004 has increased to
$3,274,281, representing an increase of $1,844,473 or 129%, when compared to
revenue of $1,429,808 for the six months ended July 31, 2003.

Revenue from the equipment rentals and sales segment of $1,006,777 increased by
$409,127, or 68.5%, in the six months ended July 31, 2004, compared to $597,650
for the six months ended July 31, 2003. This increase reflects the growth in the
business over the past year, which mainly arose from an increase in the customer
base and through our geographic expansion via our Distributor Network.

Revenue from the recruitment services and placement segment increased by
$1,431,178 to $2,246,740 for the six months ended July 31, 2004. This represents
a 175.5% increase on the six months to July 31, 2003.

Cost of sales

Cost of sales for the six months ended July 31, 2004, compared to the six months
ended July 31, 2003 are as follows:


                                 Six months ended         Six months ended
                                   July 31, 2004           July 31, 2003

Equipment rentals and sales       $  251,668  25.0%     $184,800  30.9%

Recruitment services and           1,843,075  82.0%     $595,732  73.0%
  - placement fees

Total                             $2,094,743  64.0%     $780,532  54.5%


The total Gross Profit increased by $530,262 (81.7%) in the first half of the
year to $1,179,538 compared with the six months ended July 31, 2003 of $649,276.



<PAGE>


General and administrative overheads

General and administrative overhead increased to $2,066,578 for the six months
to July 31, 2004, compared to overheads of $1,325,489 for the six months to July
31, 2003. The main reasons for the increase in expenditure are as for the items
outlined in the discussion and analysis for the three months results.


Interest expense

Net Interest expense of $24,164 for the six months to July 31, 2004, has reduced
by $13,908, or 36.5%, compared with $38,072 for the six months to July 31, 2003.
This improvement has been mainly due to the investment from stockholders and
improved cash position during the last year.

(Following three paragraphs are redundant, please remove)

Liquidity and Capital Resources

We have relied primarily on asset-based borrowings, internally generated funds,
stockholder investment and loans, together with trade credit to finance our
operations. Our capital requirements primarily result from working capital
needed to support operations, including increases in inventory and accounts
receivable. Our working capital position has improved significantly from a
deficit of $255,335 as of January 31, 2004 to a deficit of $76,857 as of July
31, 2004. This improvement has been mainly due to the contribution of proceeds
from shareholders. As of July 31, 2004, we had cash and cash equivalents of
$48,181 compared to $2,510 as of July 31, 2003.


Operating Cash Flow

Net cash used in operating activities for the six months ended July 31, 2004 was
$555,740, compared with net cash used of $196,841 for the six months ended July
31, 2003. The increase is primarily due to the rise in inventories in order to
meet future orders, accounts receivable and the loss for the period.

Credit Facilities

We have a loan agreement with bankers, HSBC, for a term loan that advanced
(pound)130,000 in January 2003 and is due for repayment by November 2007. The
loan attracts variable rate interest of 2% over UK base rate and there is a
floating charge over the assets of the Company (6.75% at July 31, 2004).

We also have an accounts receivable factoring arrangement with Venture Finance
which is secured by a floating charge over our assets. This facility has
attracts variable rate interest of 1.75% over UK base rate (6.5% at July 31,
2004).


ITEM 3. CONTROLS AND PROCEDURES

At July 31, 2004, we carried out an evaluation, under the supervision and with
the participation of our management, including our Chief Executive Officer and
Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures pursuant to Rule 13a-14 under the Securities
Exchange Act of 1934, as amended. Based upon that evaluation, the Chief
Executive Officer and Chief Financial Officer concluded that our disclosure
controls and procedures are effective in timely alerting them to material
information relating to us required to be included in our periodic SEC filings.

There have been no significant changes in our internal controls or in other
factors that could significantly affect our controls subsequent to the date of
that evaluation, and no corrective actions with regard to significant
deficiencies and material weaknesses.












<PAGE>


                           PART II - OTHER INFORMATION



ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits Item Description
     31.1                  Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     31.2                  Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     32                    Certification Pursuant to 18 U.S.C. Section 1350, as
                           Adopted Pursuant to Section 906 of the Sarbanes-Oxley
                           Act of 2002

(b) Report on Form 10-KSB

On May 17, 2004, we filed a report on Form 10-KSB relating to our results for
the year ended January 31, 2004.


(c) Report on Form 10-QSB

On June 14, 2004, we filed a report on Form 10-QSB relating to our results for
the quarter ended April 30, 2004.



                                                     SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

         Dated:  September 20, 2004.

                                               TRUE HEALTH, INC.

                                               BY: David Francis
                                                  -------------------
                                                  David Francis, CEO



                                               BY: Ian Wylie
                                                   ------------------
                                                   Ian Wylie, CFO





<PAGE>



                                  Exhibit 31.1

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, David Francis, certify that:

1.       I have reviewed the quarterly report on Form 10-QSB of True Health,
         Inc. for the period ended July 31, 2004 (this "Report");


2.          Based on my knowledge, this Report does not contain any untrue
            statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this Report;


3.          Based on my knowledge, the financial statements, and other financial
            information included in this Report, fairly present in all material
            respects the financial condition, results of operations and cash
            flows of the registrant as of, and for, the periods presented in
            this Report;


4.          The registrant's other certifying officers and I are responsible for
            establishing and maintaining disclosure controls and procedures (as
            defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant
            and we have:

(a)         designed such disclosure controls and procedures to ensure that
            material information relating to the registrant, including its
            consolidated subsidiaries, is made known to us by others within
            those entities, particularly during the period in which this Report
            is being prepared;

(b)      evaluated the  effectiveness of the registrant's  disclosure  controls
            and procedures as of a date within 90 days prior to the
            filing date of this Report (the "Evaluation Date"); and


(c)         presented in this Report our conclusions about the effectiveness of
            the disclosure controls and procedures based on our evaluation as of
            the Evaluation Date;


     5. The registrant's other certifying officers and I have disclosed, based
     on our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors:
(a)           all significant deficiencies in the design or operation of
              internal controls which could adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
(b)           any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and


     6. The registrant's other certifying officers and I have indicated in this
     Report whether or not there were significant changes in internal controls
     or in other factors that could significantly affect internal controls
     subsequent to the date of our most recent evaluation, including any
     corrective actions with regard to significant deficiencies and material
     weaknesses.

Dated: September 20, 2004


David Francis
--------------------------------------
David Francis, CEO


                                  Exhibit 31.2

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, Ian Wylie, certify that:

7.     I have reviewed the quarterly report on Form 10-QSB of True Health, Inc.
       for the period ended July 31, 2004 (this "Report");

8.     Based on my knowledge, this Report does not contain any untrue statement
       of a material fact or omit to state a material fact necessary to make the
       statements made, in light of the circumstances under which such
       statements were made, not misleading with respect to the period covered
       by this Report;

9.     Based on my knowledge, the financial statements, and other financial
       information included in this Report, fairly present in all material
       respects the financial condition, results of operations and cash flows of
       the registrant as of, and for, the periods presented in this Report;

10.    The registrant's other certifying officers and I are responsible for
       establishing and maintaining disclosure controls and procedures (as
       defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
       we have:

       (d)    designed such disclosure controls and procedures to ensure that
              material information relating to the registrant, including its
              consolidated subsidiaries, is made known to us by others within
              those entities, particularly during the period in which this
              Report is being prepared;
       (e)    evaluated the effectiveness of the registrant's disclosure
              controls and procedures as of a date within 90 days prior to the
              filing date of this Report (the "Evaluation Date"); and
       (f)    presented in this Report our conclusions about the effectiveness
              of the disclosure controls and procedures based on our evaluation
              as of the Evaluation Date;

11.    The registrant's other certifying officers and I have disclosed, based on
       our most recent evaluation, to the registrant's auditors and the audit
       committee of registrant's board of directors: (c) all significant
       deficiencies in the design or operation of internal controls which could
       adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
       (d)    any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

12.    The registrant's other certifying officers and I have indicated in this
       Report whether or not there were significant changes in internal controls
       or in other factors that could significantly affect internal controls
       subsequent to the date of our most recent evaluation, including any
       corrective actions with regard to significant deficiencies and material
       weaknesses.


Dated: September 20, 2004


Ian Wylie
--------------------------------------
Ian Wylie, CFO



                                   Exhibit 32

         Certification Pursuant to 18U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Each   of the undersigned hereby certifies, for the purposes of section 1350 of
       chapter 63 of title 18 of the United States Code, in his capacity as an
       officer of True Health, Inc. ("True Health"), that, to his knowledge, the
       quarterly report on Form 10-QSB of True Health, Inc. for the period ended
       July 31, 2004, fully complies with the requirements of Section 13(a) of
       the Securities Exchange Act of 1934 and that the information contained in
       such amendment to said report fairly presents, in all material respects,
       the financial condition and results of operation of True Health.

Dated: September 20, 2004




David Francis
--------------------------------------
David Francis, CEO




Ian Wylie
--------------------------------------
Ian Wylie, CFO